Nectar Lifesciences

Nectar Lifesciences

13.47
-0.28
(-2.04%)
hide
Key Fundamentals
Add Ratio
Market Cap
308.40 Cr
EPS
-5.07
PE Ratio
-1.73
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
44.41
52 Week Low
13.05
PB Ratio
0.32
Debt to Equity
0.60
Forecast For
Actual

Company News

View All News
Caret
negative
Nectar Lifesciences has delayed the completion date for its sale to Ceph Lifesciences Private Limited to on or before November 19, 2025. This marks the third postponement of the transaction, with previous target dates set for July 7, 2025, and September 16, 2025.
neutral
Nectar Lifesciences Limited has extended the expected completion date for its slump sale of pharmaceutical business to Ceph Lifesciences Private Limited to October 20, 2025. The transaction involves the sale of business related to manufacture, distribution, marketing and sale of active pharmaceutical ingredients and formulations. Both companies mutually agreed to the extension. Previous disclosures regarding this slump sale were made in July 2025, including an Extraordinary General Meeting notice and outcome in August 2025.
neutral
The Directorate of Revenue Intelligence conducted search operations at various premises of Nectar Lifesciences Limited under the Customs Act, 1962. The search operations began on September 15, 2025, at approximately 11:00 AM and concluded later that night. The company has fully cooperated with officials during the proceedings and responded to clarifications sought by them. Nectar Lifesciences will continue to provide any further information required by DRI. The violations or contraventions alleged are not ascertainable at this initial stage, and the financial impact cannot be determined currently. The company's operations and other activities continued as usual and were not impacted due to the search.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
-1.40 %
Net Income Growth
-2,374.00 %
Cash Flow Change
-24.59 %
ROE
-2,629.79 %
ROCE
-198.03 %
EBITDA Margin (Avg.)
-115.03 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
532
725
734
797
578
580
649
565
390
427
378
351
390
370
444
477
403
399
357
406
395
409
453
441
359
429
455
429
281
Expenses
471
660
667
721
513
531
592
511
373
397
345
345
350
337
396
427
361
396
343
371
359
371
410
393
320
385
410
585
343
EBITDA
62
66
67
76
64
49
57
54
17
31
33
6
41
33
47
50
42
3
15
35
36
38
43
49
40
44
45
-156
-62
Operating Profit %
11 %
9 %
9 %
9 %
11 %
8 %
9 %
10 %
4 %
7 %
9 %
1 %
9 %
8 %
11 %
10 %
10 %
-2 %
0 %
4 %
9 %
7 %
9 %
11 %
11 %
10 %
10 %
-36 %
-22 %
Depreciation
16
16
17
15
16
14
15
15
15
15
15
15
14
14
14
14
15
15
15
15
15
15
15
15
16
16
16
16
17
Interest
30
44
36
39
32
33
31
31
28
28
31
26
26
18
18
17
21
21
18
20
18
21
25
24
20
20
17
18
19
Profit Before Tax
15
7
14
23
16
3
10
8
-26
-11
-12
-36
1
0
15
18
6
-33
-18
2
3
2
3
11
5
9
13
-188
-97
Tax
2
1
3
5
3
0
2
1
-9
-4
-4
5
-1
-2
6
6
2
-10
-8
-2
1
1
1
11
2
3
5
-58
-34
Net Profit
13
6
11
18
14
3
8
7
-17
-7
-8
-41
2
2
10
12
4
-23
-9
4
2
1
2
1
3
6
8
-130
-63
EPS in ₹
0.59
0.26
0.49
0.78
0.61
0.11
0.37
0.33
-0.75
-0.33
-0.36
-1.83
0.08
0.08
0.43
0.52
0.17
-1.00
-0.41
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.80
-2.82

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
2,511
2,556
2,581
2,724
2,705
2,633
2,388
2,391
2,189
2,191
2,047
Fixed Assets
934
906
881
852
825
785
772
723
662
643
633
Current Assets
1,369
1,464
1,496
1,661
1,669
1,615
1,239
1,355
1,231
1,284
1,238
Capital Work in Progress
91
99
102
100
100
115
99
85
78
66
57
Investments
0
1
1
1
1
0
1
1
1
1
1
Other Assets
1,485
1,551
1,597
1,771
1,780
1,733
1,517
1,582
1,449
1,482
1,357
Total Liabilities
2,511
2,556
2,581
2,724
2,705
2,633
2,388
2,391
2,189
2,191
2,047
Current Liabilities
1,156
1,240
1,279
1,309
1,300
1,248
1,187
1,004
891
973
1,022
Non Current Liabilities
397
362
296
356
300
249
139
299
234
149
70
Total Equity
958
954
1,007
1,059
1,105
1,136
1,062
1,088
1,065
1,069
956
Reserve & Surplus
936
932
984
1,036
1,083
1,114
1,040
1,066
1,042
1,047
934
Share Capital
22
22
22
22
22
22
22
22
22
22
22

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
23
3
-24
-4
12
0
4
-8
-0
2
-1
Investing Activities
-60
-77
-18
-29
-26
-33
-29
17
52
-17
-42
Operating Activities
144
169
199
65
239
285
21
95
134
225
169
Financing Activities
-62
-89
-204
-40
-201
-252
12
-119
-186
-205
-128

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
44.53 %
44.53 %
44.53 %
44.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
16.97 %
16.61 %
3.24 %
0.73 %
1.65 %
0.81 %
0.62 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.16 %
0.19 %
0.09 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
Public / Retail
22.43 %
21.99 %
22.53 %
23.60 %
23.82 %
24.20 %
24.33 %
24.52 %
24.46 %
24.61 %
24.45 %
24.34 %
23.32 %
23.69 %
30.45 %
39.36 %
41.60 %
44.12 %
44.70 %
Others
21.77 %
22.21 %
21.67 %
20.60 %
20.38 %
20.00 %
5.26 %
5.07 %
5.13 %
4.98 %
5.14 %
5.25 %
3.88 %
3.87 %
10.49 %
15.35 %
12.04 %
10.32 %
9.67 %
No of Share Holders
0
47,394
53,304
55,124
56,073
64,012
63,909
62,940
64,422
61,582
60,283
60,761
59,946
58,230
66,741
69,482
69,241
71,977
76,470

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 29.93 42.23
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 38.98 34.57
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 39.31 32.23
07 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Jul 2025 25.05 22.76
04 Aug 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Aug 2025 22.76 16.25
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 14.02 15.23
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 15.24 14.42

Announcements

Update On Slump Sale2 days ago
Minutes Of 30Th Annual General Meeting ("AGM")10 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Proceedings Of 30Th Annual General Meeting ("AGM").Sep 29, 2025
Closure of Trading WindowSep 25, 2025
Update On Sale Of AssetsSep 16, 2025
Update On Slump SaleSep 16, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 16, 2025
Letter Sent To MembersSep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2025
Notice Of The 30Th Annual General Meeting ("AGM") For The Financial Year 2024-25.Aug 26, 2025
Reg. 34 (1) Annual Report.Aug 26, 2025
Notice Of The 30Th Annual General Meeting ("AGM") For The Financial Year 2024-25.Aug 26, 2025
Saksham Niveshak Campaign - Shareholder Outreach Initiative.Aug 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2025
Book Closure/ Cut-Off Date For The Purpose Of 30Th Annual General Meeting (AGM) For The Financial Year (FY) 2024-25Aug 14, 2025
Board Meeting Outcome for 30Th Annual General Meeting ("AGM") To Be Held On 29-09-2025 And Other Business Matters.Aug 14, 2025
Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On June 30 2025Aug 14, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 11, 2025
Board Meeting Intimation for Financial Results And Other Business Matters.Aug 11, 2025
Minutes Of 2025-26/01St Extraordinary General Meeting ("EGM").Aug 07, 2025
Revised Proceedings Of 2025-26/01St Extraordinary General Meeting ("EGM").Aug 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 04, 2025
Proceedings Of 2025-26/01St Extraordinary General Meeting ("EGM").Aug 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
General UpdatesJul 23, 2025
Outcome Of Board Meeting: Corrigendum To The Notice Of 2025-26/01St Extraordinary General Meeting (EGM).Jul 23, 2025
Board Meeting Intimation for Other Business Matters.Jul 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 12, 2025
Nectar Lifesciences Limited Has Informed The Exchange Regarding Notice Of Extraordinary General Meeting To Be Held On August 04 2025Jul 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 09, 2025
General UpdatesJul 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 08, 2025
1. Slump Sale Of Business; And 2. Sale Of AssetsJul 07, 2025
Financial Results For The Year 2024-25Jul 07, 2025
Board Meeting Intimation for Annual Audited Financial Results And Other Business Matters.Jul 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 03, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 30, 2025
Closure of Trading WindowJun 27, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 26, 2025
Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 11, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 30, 2025
Results-Delay in Financial ResultsMay 30, 2025
Board Meeting Outcome for Change In DirectorateMay 30, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.01%
1664
0.01%
0.01%

Technical Indicators

RSI(14)
Neutral
35.44
ATR(14)
Volatile
0.38
STOCH(9,6)
Oversold
5.58
STOCH RSI(14)
Oversold
19.66
MACD(12,26)
Bearish
-0.08
ADX(14)
Weak Trend
15.34
UO(9)
Bullish
26.07
ROC(12)
Downtrend And Accelerating
-6.46
WillR(14)
Oversold
-100.00